Christian Schindler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Christian Schindler has a total of 235 co-authors. Here are the top co-authors by number of shared publications:
- Nicole Probst-Hensch
Swiss Tropical and Public Health Institute, Allschwil, Switzerland
8 shared publications - Medea Imboden
Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute , Allschwil
6 shared publications Elisabeth Zemp
Affiliations Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland
5 shared publicationsA. Shiozawa
4 shared publicationsA. Wesley Burks
4 shared publicationsAdrienne Yancey
4 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by SMW Supporting Association in Swiss Medical Weekly
- Vol. 156 (10) , 4846
Age-period-cohort analysis of Swiss lung cancer mortality trends since 1969, with prediction to 2041
AIMS: Using more than five decades of national data, we examine how age, period and cohort factors influence lung cancer mortality in Switzerland, and forecast future death counts to the early 2040s. METHODS: Lung cancer deaths were extracted from Swiss vital statistics. We applied age-period-cohort (APC) modelling to lung cancer mortality rates using substantiated assumptions about the age-mortality relationship as model constraints. To account for the uncertainty in the age-mortality relationship, boundary constraints were applied to the line of APC solutions, yielding a range of plausible results. In an alternative model, we replaced the cohort terms with smoking prevalence estimates from Swiss health surveys, enabling unconstrained modelling of age and period effects. Predictions are based on modelled age trends, and linearly extrapolated period and cohort trends. RESULTS: Plausible age, period and cohort effects indicated that age-specific mortality risks decline at the oldest ages, that period effects were minimal, while cohort effects showed distinct peak risks for men born around 1909 and women born around 1954. Among women, birth cohorts with the highest mortality closely aligned with those exhibiting the highest smoking prevalence. The models predicted a decline in the number of lung cancer deaths among men beginning in the mid-2020s, and among women from the mid-2030s onwards. CONCLUSIONS: This population-based analysis of lung cancer mortality not only highlights declining mortality rates in men of all ages, but reveals an emerging downward trend among younger women. We predict that the total number of lung cancer deaths in women will begin to decrease by the mid-2030s.
- 1 October 2026
- Published by SMW Supporting Association in Swiss Medical Weekly
- Vol. 156 (10) , 4846
Open AccessAge-period-cohort analysis of Swiss lung cancer mortality trends since 1969, with prediction to 2041
AIMS: Using more than five decades of national data, we examine how age, period and cohort factors influence lung cancer mortality in Switzerland, and forecast future death counts to the early 2040s. METHODS: Lung cancer deaths were extracted from Swiss vital statistics. We applied age-period-cohort (APC) modelling to lung cancer mortality rates using substantiated assumptions about the age-mortality relationship as model constraints. To account for the uncertainty in the age-mortality relationship, boundary constraints were applied to the line of APC solutions, yielding a range of plausible results. In an alternative model, we replaced the cohort terms with smoking prevalence estimates from Swiss health surveys, enabling unconstrained modelling of age and period effects. Predictions are based on modelled age trends, and linearly extrapolated period and cohort trends. RESULTS: Plausible age, period and cohort effects indicated that age-specific mortality risks decline at the oldest ages, that period effects were minimal, while cohort effects showed distinct peak risks for men born around 1909 and women born around 1954. Among women, birth cohorts with the highest mortality closely aligned with those exhibiting the highest smoking prevalence. The models predicted a decline in the number of lung cancer deaths among men beginning in the mid-2020s, and among women from the mid-2030s onwards. CONCLUSIONS: This population-based analysis of lung cancer mortality not only highlights declining mortality rates in men of all ages, but reveals an emerging downward trend among younger women. We predict that the total number of lung cancer deaths in women will begin to decrease by the mid-2030s.
- Open Access
- 3 September 2026
- Published by Elsevier in SSRN Electronic Journal
Climate-driven increase in European beech fructification: Evidence from four decades of Swiss forest monitoring
The reproductive success of European beech (Fagus sylvatica L.) depends on masting, characterized by synchronized interannual variation in seed production. We used four decades (1984-2023) of quantitative fructification data from 103 Swiss long-term forest monitoring plots, integrating high-resolution climate records, tree vitality and dendrochronology. We examined temporal trends in masting patterns and tested three hypotheses: (1) Climate change is relevant for the observed increase in fructification (climate change hypothesis), (2) reduced vitality increases reproductive effort (environmental stress hypothesis) and (3) high fructification reduces stem growth (growth trade-off hypothesis). We developed a mixed-effects trigonometric climate model incorporating temperature and relative humidity (RH) data from the two preceding years, which explained substantial variation in annual fructification also when validated with the independent European MASTREE dataset. Our results revealed a marked increase in the frequency and intensity of masting after 2005, with mast year return intervals decreasing from historical values of 6.4 to 3.2 years. Crown transparency in prior years was negatively correlated with fructification, contradicting the environmental stress hypothesis. Dendrochronological analyses confirmed significant growth reductions during mast years, with effects persisting into the following year at approximately half the magnitude. Our results show that climate - not stress - drives the recent increase in beech masting. Our quantitative fructification model allows the prediction of masting-related growth reductions, with important implications for understanding carbon allocation dynamics in temperate European forests under climate change. An application of our model to projected future climate suggested, however, that observed increase in beech fructification will be transient.
- 3 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessClimate-driven increase in European beech fructification: Evidence from four decades of Swiss forest monitoring
The reproductive success of European beech (Fagus sylvatica L.) depends on masting, characterized by synchronized interannual variation in seed production. We used four decades (1984-2023) of quantitative fructification data from 103 Swiss long-term forest monitoring plots, integrating high-resolution climate records, tree vitality and dendrochronology. We examined temporal trends in masting patterns and tested three hypotheses: (1) Climate change is relevant for the observed increase in fructification (climate change hypothesis), (2) reduced vitality increases reproductive effort (environmental stress hypothesis) and (3) high fructification reduces stem growth (growth trade-off hypothesis). We developed a mixed-effects trigonometric climate model incorporating temperature and relative humidity (RH) data from the two preceding years, which explained substantial variation in annual fructification also when validated with the independent European MASTREE dataset. Our results revealed a marked increase in the frequency and intensity of masting after 2005, with mast year return intervals decreasing from historical values of 6.4 to 3.2 years. Crown transparency in prior years was negatively correlated with fructification, contradicting the environmental stress hypothesis. Dendrochronological analyses confirmed significant growth reductions during mast years, with effects persisting into the following year at approximately half the magnitude. Our results show that climate - not stress - drives the recent increase in beech masting. Our quantitative fructification model allows the prediction of masting-related growth reductions, with important implications for understanding carbon allocation dynamics in temperate European forests under climate change. An application of our model to projected future climate suggested, however, that observed increase in beech fructification will be transient.
- Open Access
Study protocol: Feasibility and clinical implications of real-time cerebral autoregulation monitoring in major noncardiac surgery with the Medtronic Cotrending algorithm (AUTOREGULATE-NONCARDIAC-COTRENDING)
Background: Perioperative hypotension is associated with postoperative organ injury. However, trials of hypotension avoidance have not found meaningful improvements in postoperative cardiovascular, renal, neurological or functional outcomes. One possible explanation is that organ perfusion depends on patients’ individual autoregulatory ranges. Hence, technology enabling monitoring of the autoregulatory status of vital organs, e.g. the brain, could provide a physiologic basis for personalising of blood pressure targets. However, current established methodologies for monitoring cerebral autoregulation in noncardiac surgery, e.g. the cerebral oximetry index (COx), are limited by performance and usability. The Medtronic Cotrending algorithm has been developed to provide automated, near real-time assessment of cerebral autoregulation. While feasibility was demonstrated in cardiac surgery, its applicability in major noncardiac surgery remains unknown. This study aims to evaluate the technical feasibility and clinical implications of Cotrending-based cerebral autoregulation monitoring in major noncardiac surgery. Objectives: Primary objective: To evaluate the technical feasibility of using the Medtronic Cotrending algorithm to monitor intraoperative cerebral autoregulation in real-time during major noncardiac surgery, drawing comparisons to the COx algorithm. Secondary objectives: to investigate the potential clinical implications of Cotrending-based cerebral autoregulation monitoring. Design: Single-centre, prospective cohort study. Setting: Swiss tertiary care centre Patients: Patients enrolled in AUTOREGULATE-NONCARDIAC who were monitored intraoperatively with the Medtronic INVOS™ 5100 near-infrared spectroscopy (NIRS) system. Outcomes: Technical feasibility outcomes include success rate of determination of the lower limit of cerebral autoregulation, intraoperative uptime, time to first estimate of the lower limit of cerebral autoregulation, sensitivity to external factors and to data artefacts; agreement of Cotrending-derived lower limit of cerebral autoregulation with COx-derived lower limit of cerebral autoregulation.
Open AccessStudy protocol: Feasibility and clinical implications of real-time cerebral autoregulation monitoring in major noncardiac surgery with the Medtronic Cotrending algorithm (AUTOREGULATE-NONCARDIAC-COTRENDING)
Background: Perioperative hypotension is associated with postoperative organ injury. However, trials of hypotension avoidance have not found meaningful improvements in postoperative cardiovascular, renal, neurological or functional outcomes. One possible explanation is that organ perfusion depends on patients’ individual autoregulatory ranges. Hence, technology enabling monitoring of the autoregulatory status of vital organs, e.g. the brain, could provide a physiologic basis for personalising of blood pressure targets. However, current established methodologies for monitoring cerebral autoregulation in noncardiac surgery, e.g. the cerebral oximetry index (COx), are limited by performance and usability. The Medtronic Cotrending algorithm has been developed to provide automated, near real-time assessment of cerebral autoregulation. While feasibility was demonstrated in cardiac surgery, its applicability in major noncardiac surgery remains unknown. This study aims to evaluate the technical feasibility and clinical implications of Cotrending-based cerebral autoregulation monitoring in major noncardiac surgery. Objectives: Primary objective: To evaluate the technical feasibility of using the Medtronic Cotrending algorithm to monitor intraoperative cerebral autoregulation in real-time during major noncardiac surgery, drawing comparisons to the COx algorithm. Secondary objectives: to investigate the potential clinical implications of Cotrending-based cerebral autoregulation monitoring. Design: Single-centre, prospective cohort study. Setting: Swiss tertiary care centre Patients: Patients enrolled in AUTOREGULATE-NONCARDIAC who were monitored intraoperatively with the Medtronic INVOS™ 5100 near-infrared spectroscopy (NIRS) system. Outcomes: Technical feasibility outcomes include success rate of determination of the lower limit of cerebral autoregulation, intraoperative uptime, time to first estimate of the lower limit of cerebral autoregulation, sensitivity to external factors and to data artefacts; agreement of Cotrending-derived lower limit of cerebral autoregulation with COx-derived lower limit of cerebral autoregulation.
- Open Access
PRECISION study: impact of personalised cardiac anaesthesia and cerebral autoregulation on neurological outcomes in patients undergoing cardiac surgery – protocol for an international, multicentre, prospective cohort study
Introduction: Adverse neurological complications, including postoperative delirium (POD) and stroke, remain one of the major risks after cardiac surgery. A lack of comprehensive knowledge about their causes and neuroprotective strategies has hindered the development of effective interventions to reduce these events. Personalised cerebral autoregulation (CA)-oriented blood pressure monitoring aims to identify blood pressure targets tailored to each individual patient, thereby reducing brain injury. The PRECISION study aims to assess whether perioperative duration and magnitude of mean arterial pressure (MAP) deviation from an individual’s CA limits are associated with adverse neurological complications. Methods and analysis: This international, multicentre, prospective cohort study is conducted at two Swiss and one British hospital. Patients aged 65 years or older undergoing elective primary or re-operative coronary artery bypass graft and/or valvular and/or ascending aorta surgery requiring cardiopulmonary bypass are included. Preoperatively, the patient’s baseline of physical, cognitive and mental status is established. Intraoperatively, near-infrared spectroscopy (NIRS) and transcranial Doppler (TCD) are recorded in real-time to generate NIRS-derived and TCD-derived CA indices. The primary endpoint is POD, assessed daily on postoperative days 0 to 7 or up to discharge, whichever occurs earlier with the 3D-Confusion Assessment Method (3D-CAM) or CAM-Intensive Care Unit. Secondary endpoints include a composite neurological outcome of POD and overt stroke, postoperative neurocognitive disorders, major morbidity and mortality. Associations between neurologic outcomes, neurobiomarkers and genetic variation will be explored. A total of 500 participants is required to achieve 90% power to find a statistically significant effect of the area under the curve MAP<lower limit of CA (LLA) on the risk of POD at the 5% level. This includes adjustment for potential confounders and for the inability to determine the LLA. Ethics and dissemination: Ethical approval has been obtained from all responsible ethics committees (Swiss lead ethics committee EKNZ 2022-01457 and Health Research Authority and Health and Care Research Wales, UK, REC 23/SW/0076). Results will be disseminated at national and international conferences and published in peer-reviewed journals. Trial registration number: NCT05595954 .
Open AccessPRECISION study: impact of personalised cardiac anaesthesia and cerebral autoregulation on neurological outcomes in patients undergoing cardiac surgery – protocol for an international, multicentre, prospective cohort study
Introduction: Adverse neurological complications, including postoperative delirium (POD) and stroke, remain one of the major risks after cardiac surgery. A lack of comprehensive knowledge about their causes and neuroprotective strategies has hindered the development of effective interventions to reduce these events. Personalised cerebral autoregulation (CA)-oriented blood pressure monitoring aims to identify blood pressure targets tailored to each individual patient, thereby reducing brain injury. The PRECISION study aims to assess whether perioperative duration and magnitude of mean arterial pressure (MAP) deviation from an individual’s CA limits are associated with adverse neurological complications. Methods and analysis: This international, multicentre, prospective cohort study is conducted at two Swiss and one British hospital. Patients aged 65 years or older undergoing elective primary or re-operative coronary artery bypass graft and/or valvular and/or ascending aorta surgery requiring cardiopulmonary bypass are included. Preoperatively, the patient’s baseline of physical, cognitive and mental status is established. Intraoperatively, near-infrared spectroscopy (NIRS) and transcranial Doppler (TCD) are recorded in real-time to generate NIRS-derived and TCD-derived CA indices. The primary endpoint is POD, assessed daily on postoperative days 0 to 7 or up to discharge, whichever occurs earlier with the 3D-Confusion Assessment Method (3D-CAM) or CAM-Intensive Care Unit. Secondary endpoints include a composite neurological outcome of POD and overt stroke, postoperative neurocognitive disorders, major morbidity and mortality. Associations between neurologic outcomes, neurobiomarkers and genetic variation will be explored. A total of 500 participants is required to achieve 90% power to find a statistically significant effect of the area under the curve MAP<lower limit of CA (LLA) on the risk of POD at the 5% level. This includes adjustment for potential confounders and for the inability to determine the LLA. Ethics and dissemination: Ethical approval has been obtained from all responsible ethics committees (Swiss lead ethics committee EKNZ 2022-01457 and Health Research Authority and Health and Care Research Wales, UK, REC 23/SW/0076). Results will be disseminated at national and international conferences and published in peer-reviewed journals. Trial registration number: NCT05595954 .
- Open Access
The PROTECT trial: Effect of titrated versus conventional induction of general anaesthesia using a target-controlled infusion system on haemodynamics in patients undergoing non-cardiac surgery – protocol for a multicentre, expertise-based randomised controlled trial
Introduction: Hypotension is a frequent complication after induction of general anaesthesia leading to end-organ injury, for which elderly and multimorbid patients are particularly susceptible. The extent of hypotension depends, among other factors, on the dose and rate of propofol administration. Target-controlled infusion systems are widely used to administer short-acting anaesthetics such as propofol and remifentanil. Commonly, induction is started with a fixed effect-site concentration. Titration, an alternative method of induction using an incremental augmentation of propofol, leads to a reduced induction dose and rate of propofol. We hypothesise that the titration method improves haemodynamic stability compared with conventional induction. Methods and analysis: This multicentre, expertise-based randomised controlled trial takes place at four Swiss hospitals. Patients ≥55 years of age undergoing non-cardiac surgery under general anaesthesia using propofol target-controlled infusion are randomised to either a conventional or a titrated anaesthesia induction method. Patients, statisticians and, if resources allow, outcome assessors will be blinded. The primary endpoint is the mean arterial pressure under the individual baseline mean arterial pressure (area under threshold) during the first 30 min after start of induction. Secondary endpoints include the maximum deviation from baseline mean arterial pressure, haemodynamic rescue methods, propofol consumption and neurocognitive recovery after regaining consciousness. A total of 320 patients are required to have an 80% chance of observing superiority of titration for the area under the threshold as significant at the 5% level, assuming a true difference of 100 mm Hg*min. The area under threshold and the maximum deviation will be compared between arms using mixed linear regression models. Ethics and dissemination: Ethical approval has been obtained from all responsible ethics committees (BASEC2025-01007). The results will be presented at international meetings and published in peer-reviewed journals and may contribute to a change in clinical practice for anaesthesia induction using target-controlled infusion systems with propofol. Trial registration number: clinicaltrials.gov ( NCT06980688 ) and www.humanforschung-schweiz.ch (HumRes67022).
Open AccessThe PROTECT trial: Effect of titrated versus conventional induction of general anaesthesia using a target-controlled infusion system on haemodynamics in patients undergoing non-cardiac surgery – protocol for a multicentre, expertise-based randomised controlled trial
Introduction: Hypotension is a frequent complication after induction of general anaesthesia leading to end-organ injury, for which elderly and multimorbid patients are particularly susceptible. The extent of hypotension depends, among other factors, on the dose and rate of propofol administration. Target-controlled infusion systems are widely used to administer short-acting anaesthetics such as propofol and remifentanil. Commonly, induction is started with a fixed effect-site concentration. Titration, an alternative method of induction using an incremental augmentation of propofol, leads to a reduced induction dose and rate of propofol. We hypothesise that the titration method improves haemodynamic stability compared with conventional induction. Methods and analysis: This multicentre, expertise-based randomised controlled trial takes place at four Swiss hospitals. Patients ≥55 years of age undergoing non-cardiac surgery under general anaesthesia using propofol target-controlled infusion are randomised to either a conventional or a titrated anaesthesia induction method. Patients, statisticians and, if resources allow, outcome assessors will be blinded. The primary endpoint is the mean arterial pressure under the individual baseline mean arterial pressure (area under threshold) during the first 30 min after start of induction. Secondary endpoints include the maximum deviation from baseline mean arterial pressure, haemodynamic rescue methods, propofol consumption and neurocognitive recovery after regaining consciousness. A total of 320 patients are required to have an 80% chance of observing superiority of titration for the area under the threshold as significant at the 5% level, assuming a true difference of 100 mm Hg*min. The area under threshold and the maximum deviation will be compared between arms using mixed linear regression models. Ethics and dissemination: Ethical approval has been obtained from all responsible ethics committees (BASEC2025-01007). The results will be presented at international meetings and published in peer-reviewed journals and may contribute to a change in clinical practice for anaesthesia induction using target-controlled infusion systems with propofol. Trial registration number: clinicaltrials.gov ( NCT06980688 ) and www.humanforschung-schweiz.ch (HumRes67022).
- Open Access
- 23 October 2023
- Published by Frontiers Media SA in International Journal of Public Health
- Vol. 68, 1606349
A New Global Air Quality Health Index Based on the WHO Air Quality Guideline Values With Application in Cape Town
Objectives: This study developed an Air Quality Health Index (AQHI) based on global scientific evidence and applied it to data from Cape Town, South Africa.Methods: Effect estimates from two global systematic reviews and meta-analyses were used to derive the excess risk (ER) for PM2.5, PM10, NO2, SO2 and O3. Single pollutant AQHIs were developed and scaled using the ERs at the WHO 2021 long-term Air Quality Guideline (AQG) values to define the upper level of the “low risk” range. An overall daily AQHI was defined as weighted average of the single AQHIs.Results: Between 2006 and 2015, 87% of the days posed “moderate to high risk” to Cape Town’s population, mainly due to PM10 and NO2 levels. The seasonal pattern of air quality shows “high risk” occurring mostly during the colder months of July–September.Conclusion: The AQHI, with its reference to the WHO 2021 long-term AQG provides a global application and can assist countries in communicating risks in relation to their daily air quality.
- 23 October 2023
- Published by Frontiers Media SA in International Journal of Public Health
- Vol. 68, 1606349
Open AccessA New Global Air Quality Health Index Based on the WHO Air Quality Guideline Values With Application in Cape Town
Objectives: This study developed an Air Quality Health Index (AQHI) based on global scientific evidence and applied it to data from Cape Town, South Africa.Methods: Effect estimates from two global systematic reviews and meta-analyses were used to derive the excess risk (ER) for PM2.5, PM10, NO2, SO2 and O3. Single pollutant AQHIs were developed and scaled using the ERs at the WHO 2021 long-term Air Quality Guideline (AQG) values to define the upper level of the “low risk” range. An overall daily AQHI was defined as weighted average of the single AQHIs.Results: Between 2006 and 2015, 87% of the days posed “moderate to high risk” to Cape Town’s population, mainly due to PM10 and NO2 levels. The seasonal pattern of air quality shows “high risk” occurring mostly during the colder months of July–September.Conclusion: The AQHI, with its reference to the WHO 2021 long-term AQG provides a global application and can assist countries in communicating risks in relation to their daily air quality.
- Open Access
- 2 March 2022
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 52 (5) , 670-683
Association between allergic sensitization and intestinal parasite infection in schoolchildren in Gqeberha, South Africa
Background: Inconsistent data exist regarding the influence of parasitic infection on the prevalence of allergic sensitization and disorders.Objective: To investigate the impact of geohelminth and protozoan infections on sensitization patterns and allergic symptoms of children living in low‐income communities in Gqeberha, South Africa.Methods: In a cross‐sectional study, 587 schoolchildren aged 8–12 years were recruited in June 2016 and screened for reactivity to common allergens by skin prick tests (SPTs) and for parasitic infections by stool examination. Additionally, questionnaires were completed to record allergic symptoms the children may have experienced.Results: Positive SPTs were found in 237/587 children (40.4%), and about one‐third of whom were polysensitized. Sensitizations were most frequently detected against the house dust mites (HDM) Dermatophagoides spp. (31.9%) and Blomia tropicalis (21.0%). Infections with geohelminths (Ascaris lumbricoides, Trichuris trichiura) were found in 26.8% and protozoan infections (Giardia intestinalis, Cryptosporidia spp.) in 13.9% of study participants. Mixed logistic regression analyses revealed negative associations between parasite infection and sensitization to Blomia tropicalis (OR: 0.54, 95% CI 0.33–0.89) and to Dermatophagoides spp. (OR 0.65, 95% CI 0.43–0.96), and between protozoan infection and allergic sensitization to any aeroallergen, although these associations were not significant when adjusted for false discovery. Geohelminth infection and intensity of geohelminth infection were both associated with reduced risk of polysensitization (OR 0.41, 95% CI 0.21–0.86), and this association remained significant with adjustment for false discovery. Reported respiratory symptoms were associated with HDM sensitization (ORs from 1.54 to 2.48), but not with parasite infection.Conclusions and clinical relevance: Our data suggest that geohelminth infection and high geohelminth infection intensity are associated with a reduced risk of polysensitization.
- 2 March 2022
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 52 (5) , 670-683
Open AccessAssociation between allergic sensitization and intestinal parasite infection in schoolchildren in Gqeberha, South Africa
Background: Inconsistent data exist regarding the influence of parasitic infection on the prevalence of allergic sensitization and disorders.Objective: To investigate the impact of geohelminth and protozoan infections on sensitization patterns and allergic symptoms of children living in low‐income communities in Gqeberha, South Africa.Methods: In a cross‐sectional study, 587 schoolchildren aged 8–12 years were recruited in June 2016 and screened for reactivity to common allergens by skin prick tests (SPTs) and for parasitic infections by stool examination. Additionally, questionnaires were completed to record allergic symptoms the children may have experienced.Results: Positive SPTs were found in 237/587 children (40.4%), and about one‐third of whom were polysensitized. Sensitizations were most frequently detected against the house dust mites (HDM) Dermatophagoides spp. (31.9%) and Blomia tropicalis (21.0%). Infections with geohelminths (Ascaris lumbricoides, Trichuris trichiura) were found in 26.8% and protozoan infections (Giardia intestinalis, Cryptosporidia spp.) in 13.9% of study participants. Mixed logistic regression analyses revealed negative associations between parasite infection and sensitization to Blomia tropicalis (OR: 0.54, 95% CI 0.33–0.89) and to Dermatophagoides spp. (OR 0.65, 95% CI 0.43–0.96), and between protozoan infection and allergic sensitization to any aeroallergen, although these associations were not significant when adjusted for false discovery. Geohelminth infection and intensity of geohelminth infection were both associated with reduced risk of polysensitization (OR 0.41, 95% CI 0.21–0.86), and this association remained significant with adjustment for false discovery. Reported respiratory symptoms were associated with HDM sensitization (ORs from 1.54 to 2.48), but not with parasite infection.Conclusions and clinical relevance: Our data suggest that geohelminth infection and high geohelminth infection intensity are associated with a reduced risk of polysensitization.
- Open Access
- 27 July 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (7) , e0255077
Posttraumatic stress disorder predicts poor health-related quality of life in cardiac patients in Palestine
Background: The longitudinal association of posttraumatic stress disorder (PTSD) with health-related quality of life (HRQL) in cardiac patients’ remains poorly studied, particularly in conflict-affected settings. Materials and methods: For this cohort study, we used baseline and one-year follow-up data collected from patients 30 to 80 years old consecutively admitted with a cardiac diagnosis to four major hospitals in Nablus, Palestine. All subjects were screened for PTSD and HRQL using the PTSD Checklist Specific and the HeartQoL questionnaire. We used a generalized structural equation model (GSEM) to examine the independent predictive association of PTSD at baseline with HRQL at follow-up. We also examined the mediating roles of depression, anxiety, and stress at baseline. Results: The prevalence of moderate-to-high PTSD symptoms among 1022 patients at baseline was 27∙0%. Patients with PTSD symptoms reported an approximate 20∙0% lower HRQL at follow-up. The PTSD and HRQL relationship was largely mediated by depressive and anxiety symptoms. It was not materially altered by adjustment for socio-demographic, clinical, and lifestyle factors. Discussion: Our findings suggest that individuals with a combination of PTSD and depression, or anxiety are potentially faced with poor HRQL as a longer-term outcome of their cardiac disease. In Palestine, psychological disorders are often stigmatized; however, integration of mental health care with cardiac care may offer an entry door for addressing psychological problems in the population. Further studies need to assess the effective mental health interventions for improving quality of life in cardiac patients.
- 27 July 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (7) , e0255077
Open AccessPosttraumatic stress disorder predicts poor health-related quality of life in cardiac patients in Palestine
Background: The longitudinal association of posttraumatic stress disorder (PTSD) with health-related quality of life (HRQL) in cardiac patients’ remains poorly studied, particularly in conflict-affected settings. Materials and methods: For this cohort study, we used baseline and one-year follow-up data collected from patients 30 to 80 years old consecutively admitted with a cardiac diagnosis to four major hospitals in Nablus, Palestine. All subjects were screened for PTSD and HRQL using the PTSD Checklist Specific and the HeartQoL questionnaire. We used a generalized structural equation model (GSEM) to examine the independent predictive association of PTSD at baseline with HRQL at follow-up. We also examined the mediating roles of depression, anxiety, and stress at baseline. Results: The prevalence of moderate-to-high PTSD symptoms among 1022 patients at baseline was 27∙0%. Patients with PTSD symptoms reported an approximate 20∙0% lower HRQL at follow-up. The PTSD and HRQL relationship was largely mediated by depressive and anxiety symptoms. It was not materially altered by adjustment for socio-demographic, clinical, and lifestyle factors. Discussion: Our findings suggest that individuals with a combination of PTSD and depression, or anxiety are potentially faced with poor HRQL as a longer-term outcome of their cardiac disease. In Palestine, psychological disorders are often stigmatized; however, integration of mental health care with cardiac care may offer an entry door for addressing psychological problems in the population. Further studies need to assess the effective mental health interventions for improving quality of life in cardiac patients.
- Open Access
- 1 April 2019
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 38 (4) , 333-339
Immunologic-based Diagnosis of Latent Tuberculosis Among Children Younger Than 5 Years of Age Exposed and Unexposed to Tuberculosis in Tanzania
Background: Childhood tuberculosis (TB) is acquired after exposure to an infectious TB case, often within the household. We prospectively screened children 6–59 months of age, exposed and unexposed to an infectious TB case within the same household, for latent tuberculosis infection (LTBI), in Dar es Salaam, Tanzania. Methods: We collected medical data and clinical specimens (to evaluate for helminths, TB and HIV coinfections) and performed physical examinations at enrollment and at 3-month and 6-month follow-up surveys. LTBI was assessed using QuantiFERON-TB Gold (QFT) at enrollment and at 3 months. Results: In total, 301 children had complete data records (186 with TB exposure and 115 without known TB exposure). The median age of children was 26 months (range: 6–58); 52% were females, and 4 were HIV positive. Eight children (3%) developed TB during the 6-month follow-up. We found equal proportions of children with LTBI among those with and without exposure: 20% (38/186) versus 20% (23/115) QFT-positive, and 2% (4/186) versus 4% (5/115) indeterminate QFT. QFT conversion rate was 7% (22 children) and reversion 8% (25 children). Of the TB-exposed children, 72% initiated isoniazid preventive therapy, but 61% of parents/caregivers of children with unknown TB exposure and positive QFT refused isoniazid preventive therapy. Conclusions: In this high burden TB setting, TB exposure from sources other than the household was equally important as household exposure. Nearly one third of eligible children did not receive isoniazid preventive therapy. Evaluation for LTBI in children remains an important strategy for controlling TB but should not be limited to children with documented TB exposure.
- 1 April 2019
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 38 (4) , 333-339
Open AccessImmunologic-based Diagnosis of Latent Tuberculosis Among Children Younger Than 5 Years of Age Exposed and Unexposed to Tuberculosis in Tanzania
Background: Childhood tuberculosis (TB) is acquired after exposure to an infectious TB case, often within the household. We prospectively screened children 6–59 months of age, exposed and unexposed to an infectious TB case within the same household, for latent tuberculosis infection (LTBI), in Dar es Salaam, Tanzania. Methods: We collected medical data and clinical specimens (to evaluate for helminths, TB and HIV coinfections) and performed physical examinations at enrollment and at 3-month and 6-month follow-up surveys. LTBI was assessed using QuantiFERON-TB Gold (QFT) at enrollment and at 3 months. Results: In total, 301 children had complete data records (186 with TB exposure and 115 without known TB exposure). The median age of children was 26 months (range: 6–58); 52% were females, and 4 were HIV positive. Eight children (3%) developed TB during the 6-month follow-up. We found equal proportions of children with LTBI among those with and without exposure: 20% (38/186) versus 20% (23/115) QFT-positive, and 2% (4/186) versus 4% (5/115) indeterminate QFT. QFT conversion rate was 7% (22 children) and reversion 8% (25 children). Of the TB-exposed children, 72% initiated isoniazid preventive therapy, but 61% of parents/caregivers of children with unknown TB exposure and positive QFT refused isoniazid preventive therapy. Conclusions: In this high burden TB setting, TB exposure from sources other than the household was equally important as household exposure. Nearly one third of eligible children did not receive isoniazid preventive therapy. Evaluation for LTBI in children remains an important strategy for controlling TB but should not be limited to children with documented TB exposure.